Back
Aligos Therapeutics Stock Predictions

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
ALGS
Aligos Therapeutics
Last Price:
$9.12
Seasonality Move:
-24.68%
7 Day Trial
ALL ACCESS PASS
$
7
Aligos Therapeutics Stock Forecast
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 51.7% based on the past 4 years of stock performance.
-
Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Aligos Therapeutics Stock Undervalued?The current Aligos Therapeutics [ALGS] share price is $9.13. The Score for ALGS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Aligos Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 51.7% based on the past 4 years of stock performance.
Aligos Therapeutics Stock Rating
Sell
46
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics overpriced?
-
Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Aligos Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com
52-Week Data
52-Week High:
46.80
52-Week Low:
3.76
Prediction Charts
Market Cap:
55.8M
Price in USD:
9.13
Volume:
47.5K
Beta:
2.79
Technical Analysis
SMA50:
7.33
SMA100:
7.48
SMA200:
15.21
52-Wk Change:
-32.37%
Stock Predictions
-
Is Aligos Therapeutics stock public?Yes, Aligos Therapeutics is a publicly traded company.
-
What is the Aligos Therapeutics stock quote today?The Aligos Therapeutics stock price is 9.13 USD today.
-
How to buy Aligos Therapeutics stock online?You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jul-8 | 7.60 | 8.24 | 8.50 | 7.60 |
Jul-9 | 8.38 | 8.66 | 9.10 | 8.18 |
Jul-10 | 8.64 | 8.79 | 8.88 | 8.43 |
Jul-11 | 8.80 | 8.36 | 8.85 | 8.26 |
Jul-14 | 8.25 | 8.69 | 8.80 | 8.13 |
Jul-15 | 8.69 | 8.50 | 8.95 | 8.26 |
Jul-16 | 8.64 | 8.68 | 8.69 | 8.20 |
Jul-17 | 8.80 | 9.04 | 9.30 | 8.61 |
Jul-18 | 9.19 | 9.16 | 9.48 | 8.84 |
Jul-21 | 9.24 | 8.64 | 9.92 | 8.64 |
Jul-22 | 8.70 | 9.12 | 9.22 | 8.18 |
Jul-23 | 9.16 | 9.28 | 9.44 | 8.94 |
Jul-24 | 8.95 | 8.91 | 9.11 | 8.67 |
Jul-25 | 9.02 | 9.13 | 9.20 | 8.58 |
Aligos Therapeutics Earnings
Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aligos Therapeutics Forecast Revenue Growth
Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.